4ArrayExpress Uploader0humanrefractory anemia with excess blastsMDS1myelodysplastic syndromerefractory anemiaMDS10myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS11myelodysplastic syndromerefractory anemiaMDS12myelodysplastic syndromerefractory anemiaMDS13myelodysplastic syndromerefractory anemia with excess blastsMDS14myelodysplastic syndromerefractory anemia with excess blastsMDS15myelodysplastic syndromerefractory anemiaMDS16myelodysplastic syndromerefractory anemia with excess blastsMDS17myelodysplastic syndromerefractory anemiaMDS18myelodysplastic syndromerefractory anemiaMDS19myelodysplastic syndromerefractory anemiaMDS2myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS20myelodysplastic syndromerefractory anemia with excess blastsMDS21myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS22myelodysplastic syndromerefractory anemia with excess blastsMDS23myelodysplastic syndromerefractory anemia with excess blastsMDS24myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS25myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS26myelodysplastic syndromerefractory anemia with excess blastsMDS27myelodysplastic syndromerefractory anemia with excess blastsMDS28myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS29myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS3myelodysplastic syndromerefractory anemia with excess blastsMDS30myelodysplastic syndromerefractory anemiaMDS31myelodysplastic syndromerefractory anemiaMDS32myelodysplastic syndromerefractory anemia with excess blastsMDS33myelodysplastic syndromerefractory anemiaMDS34myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS35myelodysplastic syndromerefractory anemia with excess blastsMDS36myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS37myelodysplastic syndromerefractory anemiaMDS38myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS39myelodysplastic syndromerefractory anemiaMDS4myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS40myelodysplastic syndromerefractory anemiaMDS41myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS42myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS43myelodysplastic syndromerefractory anemia with excess blastsMDS44myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS45myelodysplastic syndromerefractory anemiaMDS46myelodysplastic syndromerefractory anemia with excess blastsMDS47myelodysplastic syndromerefractory anemiaMDS48myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS49myelodysplastic syndromerefractory anemia with excess blastsMDS5myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS50myelodysplastic syndromerefractory anemiaMDS51myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS52myelodysplastic syndromerefractory anemia with excess blastsMDS53myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS54myelodysplastic syndromerefractory anemiaMDS55myelodysplastic syndromerefractory anemia with ringed sideroblastsMDS6myelodysplastic syndromerefractory anemia with excess blastsMDS7myelodysplastic syndromerefractory anemia with excess blastsMDS8myelodysplastic syndromerefractory anemiaMDS9myelodysplastic syndromenormalN1normalnormalN10normalnormalN11normalnormalN2normalnormalN3normalnormalN4normalnormalN5normalnormalN6normalnormalN7normalnormalN8normalnormalN9normal4650arrayexpress_sidhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-461955 patients with MDS and 11 healthy controls were included in the study. At the time of investigation, 18 patients had RA, 19 RARS and 18...16527891/profile/8773/arrayexpressuploader366bonebone marrowcellgenomeDec.12, 2014Falsetranscription-profiling-of-human-cd43-cells-isolatE-GEOD-4619_A-AFFY-44Transcription profiling of human CD43+ cells isolated from myelodysplastic syndrome patients and normal controls reveals involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.Sep.21, 201455 patients with MDS and 11 healthy controls were included in the study. At the time of investigation, 18 patients had RA, 19 RARS and 18 RAEB. The RAEB group was further subdivided into RAEB1 and RAEB2 for a selected part of the analysis. Bone marrow samples were obtained and CD34+ cells isolated from MDS patients and healthy controls using MACS magnetic cell separation columns. Total RNA was extracted using TRIZOL following the protocol supplied by the manufacturer. RNA was amplified using the Two-Cycle cDNA Synthesis and the Two-Cycle Target Labelling and Control Reagent packages (Affymetrix). Samples were hybridized to GeneChip Human Genome U133 Plus 2.0 arrays. Affymetrix CEL files were pre-processed using Robust MultiChip Analysis (RMA).E-GEOD-4619http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-4619/samples/